APA (7th ed.) Citation

Sakai, F., Ozeki, A., & Skljarevski, V. (2020). Efficacy and safety of galcanezumab for prevention of migraine headache in Japanese patients with episodic migraine: A phase 2 randomized controlled clinical trial. Cephalalgia reports, 3, . https://doi.org/10.1177/2515816320932573

Chicago Style (17th ed.) Citation

Sakai, Fumihiko, Akichika Ozeki, and Vladimir Skljarevski. "Efficacy and Safety of Galcanezumab for Prevention of Migraine Headache in Japanese Patients with Episodic Migraine: A Phase 2 Randomized Controlled Clinical Trial." Cephalalgia Reports 3 (2020). https://doi.org/10.1177/2515816320932573.

MLA (9th ed.) Citation

Sakai, Fumihiko, et al. "Efficacy and Safety of Galcanezumab for Prevention of Migraine Headache in Japanese Patients with Episodic Migraine: A Phase 2 Randomized Controlled Clinical Trial." Cephalalgia Reports, vol. 3, 2020, https://doi.org/10.1177/2515816320932573.